| Literature DB >> 32821080 |
Lijalem Melie Tesfaw1, Essey Kebede Muluneh1.
Abstract
BACKGROUND: Cancer is the second leading cause of death globally. Despite developing countries including Ethiopia continuing to shoulder the greatest burden, insufficient research has been conducted to determine geographical and other characteristic effects. The main objective of this study was to assess the distribution and risk of cancer and determine the effects of some common clinical patient characteristics on current patient status by taking into account the spatial effect.Entities:
Keywords: Incidence of cancer; patient status; spatial mixed OLR
Year: 2020 PMID: 32821080 PMCID: PMC7412629 DOI: 10.1177/1176935120939898
Source DB: PubMed Journal: Cancer Inform ISSN: 1176-9351
Figure 1.An overview map of the study region (yellow highlighted) in Amhara, Ethiopia, that consists of 6 zones. AW indicates Awi; BN, Benshangul; EG, East Gojjam; SG, South Gondar; SW, South Wollo; WG, West Gojjam.
Description of variables considered in this study.
| Independent variables | Frequency (%) |
|---|---|
| Characteristics and risk factors | |
| Age | |
| Gender | |
| Female (0) | 257 (61.93) |
| Male (1) | 158 (38.07) |
| Residence blood type | |
| A+ | 106 (25.54) |
| A | 18 (4.34) |
| AB+ | 17 (4.10) |
| AB− | 4(0.96) |
| B+ | 101 (24.34) |
| B− | 16 (3.86) |
| O+ | 121 (29.16) |
| O− | 32 (7.71) |
| Prognostic factor | |
| Stage | |
| I | 64 (15.42) |
| II | 98 (23.62) |
| III | 114 (27.47) |
| IV | 139 (33.49) |
| Complication | |
| Anemia at diagnosis | |
| 1 = yes | 227 (54.70) |
| 0 = no | 188 (45.30) |
| Treatment | |
| Chemotherapy | 285 (68.67) |
| Chemotherapy and surgery | 120 (28.92) |
| Palliative care | 10 (2.41) |
| Dependent variable | |
| Patient status | |
| 0 = cured | 6 (1.45) |
| 1 = improved | 191 (46.02) |
| 2 = same | 108 (26.02) |
| 3 = deteriorate | 85 (20.45) |
| 4 = death | 25 (6.02) |
Key: Residence = expressed in districts from 6 zones: West Gojjam (WG), East Gojjam (EG), Awi (AW), South Gondar (SG), South Wollo (SW), and Benshangul (BN).
Figure 2.Distribution of the number of female (blue color) and male (red color) patients within different cancer types. CLL indicates chronic lymphocytic leukemia; HCC, hepatocellular carcinoma; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; RBCT, round blue cell tumor.
Cancer types and respective number of patients.
| Cancer type | No. of patients | Percent |
|---|---|---|
| Breast | 80 | 19.28 |
| CLL | 7 | 1.69 |
| Cervical | 52 | 12.53 |
| Colonic | 10 | 2.41 |
| Endometrial | 2 | 0.48 |
| Esophagus | 5 | 1.2 |
| Gastric | 9 | 2.17 |
| HCC | 12 | 2.89 |
| HL | 7 | 1.69 |
| Head and neck | 7 | 1.69 |
| Lung | 29 | 6.99 |
| NHL | 70 | 16.87 |
| Nasopharyngeal | 2 | 0.48 |
| Ovarian | 36 | 8.67 |
| Pancreas | 12 | 2.89 |
| RBCT | 6 | 1.45 |
| Rectal | 13 | 3.13 |
| Sarcoma | 50 | 12.05 |
| Testicular | 4 | 0.96 |
| Skin (SCCA) | 2 | 0.48 |
Abbreviations: CLL, chronic lymphocytic leukemia; HCC, hepatocellular carcinoma; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; RBCT, round blue cell tumor; SCCA, squamous cell carcinoma antigen.
Districts within zones, respective number of patients, and total number inhabitants (population at risk).
| Zone | District | No. of patients (%) | Population at risk |
|---|---|---|---|
| WG | North Achefer | 20 (4.82) | 138 114 |
| South Achefer | 14 (3.37) | 119 578 | |
| Burie | 9 (2.17) | 109 389 | |
| Bahir Dar | 46 (11.08) | 620 900 | |
| Bahir Dar Zuria | 28 (6.75) | 182 794 | |
| Dembecha | 10 (2.41) | 100 897 | |
| Finote Selam | 8 (1.93) | 28 993 | |
| Gonji Kolela | 10 (2.41) | 98 654 | |
| Mecha | 26 (6.27) | 287 569 | |
| Merawi | 5 (1.20) | 32 318 | |
| Sekela | 6 (1.45) | 114 425 | |
| Woberma | 5 (1.20) | 85 283 | |
| Jabi Tehnan | 15 (3.61) | 140 012 | |
| Yilmanadensa | 17 (4.10) | 195 613 | |
| EG | Bibugn | 6 (1.45) | 83 243 |
| Debre Markos | 5 (1.20) | 91 340 | |
| Enebse Sarmidr | 5 (1.20) | 106 630 | |
| Enemay | 2 (0.48) | 140 905 | |
| Goncha Siso enese | 5 (1.20) | 121 133 | |
| Hulet ejun enese | 11 (2.65) | 251 845 | |
| Machakel | 4 (0.96) | 108 270 | |
| Mota | 7 (1.69) | 54 057 | |
| AW | Ankasha Guagusa | 15 (3.61) | 187 144 |
| Banja | 9 (2.17) | 104 599 | |
| Chagni | 5 (1.20) | 34 017 | |
| Dangla | 13 (3.13) | 131 897 | |
| Fagita Lekoma | 5 (1.20) | 117 249 | |
| Guangua | 4 (0.96) | 203 196 | |
| Jawi | 6 (1.45) | 66 012 | |
| SG | Alefa | 5 (1.20) | 129 215 |
| Libo Kemkem | 15 (3.61) | 209 760 | |
| Debre Tabor | 5 (1.20) | 62 989 | |
| Dera | 18 (4.34) | 217 513 | |
| Estie | 10 (2.41) | 308 929 | |
| Ebinat | 9 (2.17) | 192 235 | |
| Farta | 6 (1.45) | 201 790 | |
| Fogera | 9 (2.17) | 196 682 | |
| Gaynt | 5 (1.20) | 250 518 | |
| Smada | 3 (0.72) | 207 532 | |
| SW | Dessie | 6 (1.45) | 118 372 |
| BN | Pawi | 3 (0.72) | 47 829 |
Abbreviations: AW, Awi; BN, Benshangul; EG, East Gojjam; SG, South Gondar; SW, South Wollo; WG, West Gojjam.
Incidence of cancer disease per 100 000 standardized population at risk of each district.
| District | Longitude | Latitude | Incidence of cancer | Population at risk |
|---|---|---|---|---|
| Finote Selam | 10.71 | 37.26 | 19.59 | 28 993 |
| Chagni | 10.95 | 36.50 | 14.70 | 34 017 |
| Merawi | 11.25 | 36.50 | 13.40 | 32 318 |
| Mota | 11.08 | 37.87 | 12.95 | 54 057 |
| Bahir Dar Zuria | 11.25 | 37.17 | 12.51 | 182 794 |
| North Achefer | 11.60 | 37.03 | 10.63 | 138 114 |
| Gonji Kolela | 11.45 | 37.67 | 8.65 | 98 654 |
| South Achefer | 11.83 | 37.17 | 8.26 | 119 578 |
| Debre Tabor | 11.85 | 38.22 | 7.94 | 62 989 |
| Mecha | 11.50 | 37.00 | 7.87 | 287 569 |
| Jabi Tehnan | 10.80 | 37.17 | 7.73 | 140 012 |
| Banja | 11.17 | 36.25 | 7.61 | 104 599 |
| Dangla | 11.42 | 36.67 | 7.56 | 131 897 |
| Dembecha | 10.67 | 37.17 | 7.10 | 100 897 |
| Debre Markos | 10.23 | 37.32 | 7.01 | 91 340 |
| Jawi | 11.75 | 36.42 | 6.96 | 66 012 |
| Ankasha Guagusa | 11.00 | 36.67 | 6.91 | 187 144 |
| Yilmanadensa | 11.50 | 37.33 | 6.86 | 195 613 |
| Bibugn | 11.00 | 37.58 | 6.80 | 83 243 |
| Bahir Dar | 11.60 | 37.38 | 6.75 | 620 900 |
| Dera | 11.75 | 37.50 | 6.73 | 217 513 |
| Pawi | 11.33 | 36.33 | 6.27 | 47 829 |
| Libo Kemkem | 12.33 | 37.68 | 6.01 | 209 760 |
| Burie | 10.70 | 37.06 | 5.76 | 109 389 |
| Woberma | 10.37 | 35.75 | 4.53 | 85 283 |
| Sekela | 11.17 | 37.00 | 3.99 | 114 425 |
| Ebinat | 12.17 | 38.08 | 3.88 | 192 235 |
| Dessie | 11.13 | 38.53 | 3.78 | 118 372 |
| Fogera | 11.97 | 37.68 | 3.65 | 196 682 |
| Hulet ejun enese | 11.25 | 37.75 | 3.64 | 251 845 |
| Fagita Lekoma | 11.33 | 36.75 | 3.64 | 117 249 |
| Enebse Sarmidr | 11.08 | 38.25 | 3.41 | 106 630 |
| Machakel | 10.67 | 37.33 | 3.12 | 108 270 |
| Goncha Siso enese | 11.17 | 38 | 3.10 | 121 133 |
| Alefa | 12.25 | 36.33 | 2.79 | 129 215 |
| Estie | 11.67 | 38.17 | 2.79 | 308 929 |
| Farta | 12.00 | 38.00 | 2.38 | 201 790 |
| Guangua | 11.00 | 35.25 | 1.64 | 203 196 |
| Gaynt | 12.00 | 38.33 | 1.49 | 250 518 |
| Smada | 11.50 | 38.25 | 1.21 | 207 532 |
| Enemay | 10.67 | 38.00 | 1.11 | 140 905 |
Figure 3.Incidence of cancer in different age groups for women (black color) and men (red color).
Figure 4.Spatial distribution of the incidence of cancer (per 100 000 population) in the respective location specified by longitude and latitude for each districts.
Association between patient status and covariates (N = 415).
| Covariates | Patient Status | |||||
|---|---|---|---|---|---|---|
| Cured, No. (%) | Improved, No. (%) | Same, No. (%) | Deteriorate, No. (%) | Death, No. (%) | ||
| Anemia | ||||||
| No | 6 (100) | 118 (61.8) | 57 (52.8) | 38 (44.7) | 8 (32.0) | .001 |
| Yes | 0 (0.0) | 73 (38.2) | 51 (47.2) | 47 (55.3) | 17 (68.0) | |
| Blood group | ||||||
| A− | 0 (0.0) | 8 (4.2) | 5 (4.6) | 5 (5.9) | 0 (0.0) | .89 |
| A+ | 1 (14.29) | 47 (24.6) | 24 (22.2) | 25 (29.4) | 9 (36.0) | |
| AB− | 0 (0.0) | 2 (1.0) | 2 (1.9) | 0 (0.0) | 0 (0.0) | |
| AB+ | 0 (0.0) | 8 (4.2) | 5 (4.6) | 3 (3.5) | 1 (4.0) | |
| B− | 0 (0.0) | 7 (3.7) | 3 (2.8) | 6 (7.1) | 0 (0.0) | |
| B+ | 1 (14.29) | 49 (25.7) | 26 (24.1) | 19 (22.4) | 6 (24.0) | |
| O− | 2 (28.57) | 13 (6.8) | 7 (6.5) | 9 (10.6) | 1 (4.0) | |
| O+ | 3 (42.86) | 57 (29.8) | 36 (33.3) | 18 (21.2) | 8 (32.0) | |
| Treatment | ||||||
| Chemotherapy | 3 (50.0) | 124 (64.9) | 82 (75.9) | 58 (68.2) | 18 (72.0) | .001 |
| Combined | 2 (33.3) | 66 (34.6) | 22 (20.4) | 26 (30.6) | 4 (16.0) | |
| Palliative | 1 (16.7) | 1 (0.5) | 4 (3.7) | 1 (1.2) | 3 (12.0) | |
| Sex | ||||||
| Female | 3 (50.0) | 112 (58.6) | 65 (60.2) | 59 (69.4) | 18 (72.0) | 0.346 |
| Male | 3 (50.0) | 79 (41.4) | 43 (39.8) | 26 (30.6) | 7 (28.0) | |
| Stage | ||||||
| I | 3 (50) | 34 (17.80) | 17 (16.04) | 11 (12.94) | 1 (4.00) | .000 |
| II | 1 (16.67) | 62 (32.46) | 25 (23.58) | 7 (8.24) | 3 (12.00) | |
| III | 1 (16.67) | 66 (34.55) | 30 (28.30) | 12 (14.12) | 5 (20.00) | |
| IV | 1 (16.67) | 29 (15.18) | 34 (32.08) | 55 (64.71) | 16 (64.00) | |
key: Combined = both chemotherapy and surgery.
Indicator of spatial autocorrelation.
| Indicator | Statistic | |
|---|---|---|
| Moran’s | −0.0491 | .0022 |
Parameter estimates using intercept-only OLR model, spatial OLR model, and spatial mixed OLR model.
| Parameter | Intercept-only OLR model | Spatial OLR model | Spatial mixed OLR model | |||||
|---|---|---|---|---|---|---|---|---|
| Estimate (SE) | Estimate (SE) | Overall | Estimate (SE) | Overall | ||||
| Intercept | ||||||||
| Cure | −4.222 (0.4112) | <.0001 | −4.3954 (0.5702) | <.0001 | −6.2469 (0.9357) | <.0001 | ||
| Improved | −0.1013 (0.0983) | .3028 | 0.1292 (0.4159) | .7561 | −1.6466 (0.8322) | .0625 | ||
| Same | 1.0198 (0.1112) | <.0001 | 1.6861 (0.4242) | <.0001 | −0.03957 (0.8276) | .9624 | ||
| Deteriorate | 2.7473 (0.2063) | <.0001 | 3.8532 (0.4754) | <.0001 | 2.1793 (0.8518) | .0192 | ||
| Death | 0.0000 | 0.0000 | 0.0000 | |||||
| Age |
|
| −0.0028 (0.0064) | .6612 | .6612 | −0.0030 (0.0067) | .6570 | .6570 |
| Anemia |
|
| ||||||
| No | 0.3270 (0.0989) | .0009 | .0009 | 0.6034 (0.2029) | .0031 | .0031 | ||
| Yes | 0.0000 | 0.0000 | ||||||
| Treatment |
|
| ||||||
| Chemotherapy | 0.3329 (0.2194) | .1292 | 1.4549 (0.6084) | .0173 | ||||
| Combined | 0.8145 (0.2409) | .0007 | .0031 | 1.9799 (0.6336) | .0019 | .0035 | ||
| Palliative | 0.0000 | 0.000 | ||||||
| Stage |
|
| ||||||
| I | −0.1649 (0.2845) | .5622 | .0001 | −0.6460 (0.5684) | .2564 | .0001 | ||
| II | −0.8235 (0.2352) | .0005 | −1.2438 (0.5360) | .0208 | ||||
| III | −0.3421 (0.2165) | .1141 | −0.7285 (0.5293) | .1695 | ||||
| IV | 0.0000 | 0.0000 | ||||||
| Spatial variable |
|
| −0.0201 (0.0082) | .0141 | .0141 | −0.0208 (0.0083) | .0126 | .0126 |
| Variance component | ||||||||
| Sigma11
|
|
| 0.2997 (0.2339) | |||||
| AIC (BIC) | 1056.067 (1072.180) | 924.848 (981.244) | 923.040 (937.970) | |||||
Abbreviations: –, the corresponding variable was not included in the model; /, not applicable in the model; *, reference categories; AIC, Akaike information criterion; BIC, Bayesian information criterion; OLR, ordinary logistic regression.